40,103 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Peak Retirement Planning Inc.

Peak Retirement Planning Inc. purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 40,103 shares of the company's stock, valued at approximately $1,026,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health during the 4th quarter worth approximately $26,000. UMB Bank n.a. increased its holdings in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC increased its stake in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares during the period. Institutional investors own 98.05% of the company's stock.

Analyst Ratings Changes

OPCH has been the topic of a number of analyst reports. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Trading Up 1.6%

Option Care Health stock traded up $0.51 during mid-day trading on Thursday, reaching $32.25. 1,086,144 shares of the company traded hands, compared to its average volume of 1,988,466. The firm's 50 day moving average price is $32.83 and its 200 day moving average price is $29.48. The firm has a market capitalization of $5.28 billion, a price-to-earnings ratio of 27.10, a P/E/G ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period last year, the business earned $0.26 EPS. Option Care Health's revenue was up 16.3% compared to the same quarter last year. On average, analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.